Unlock all Features See Plans and Pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
Johnson and Johnson

Last Updated: June 25, 2022

Adma Biologics, Inc. Company Profile

✉ Email this page to a colleague

« Back to Dashboard

Summary for Adma Biologics, Inc.

Biologic Drugs for Adma Biologics, Inc.

Applicant Tradename Biologic Ingredient Dosage Form BLA Approval Date Patent No. Patent Expiration
Adma Biologics, Inc. NABI-HB hepatitis b immune globulin (human) Injection 103945 2001-10-23 See Plans and Pricing
Adma Biologics, Inc. BIVIGAM immune globulin intravenous (human) Injection 125389 2012-12-19 See Plans and Pricing
Adma Biologics, Inc. ASCENIV immune globulin intravenous, human-slra Injection 125590 2019-04-01 See Plans and Pricing
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Approval Date >Patent No. >Patent Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.